MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 116 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q4 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,273,080 | -17.0% | 5,927,308 | +3.2% | 0.00% | 0.0% |
| Q2 2023 | $71,420,481 | -13.6% | 5,745,815 | -2.6% | 0.00% | 0.0% |
| Q1 2023 | $82,657,809 | +0.0% | 5,899,915 | +2.2% | 0.00% | -33.3% |
| Q4 2022 | $82,624,623 | -43.2% | 5,773,908 | +1.4% | 0.00% | -40.0% |
| Q3 2022 | $145,408,000 | -11.9% | 5,695,511 | -2.0% | 0.01% | 0.0% |
| Q2 2022 | $165,072,000 | -21.8% | 5,810,340 | -2.9% | 0.01% | -16.7% |
| Q1 2022 | $210,981,000 | -16.8% | 5,981,894 | -1.2% | 0.01% | 0.0% |
| Q4 2021 | $253,622,000 | +11.5% | 6,053,047 | +30.7% | 0.01% | 0.0% |
| Q3 2021 | $227,377,000 | +38.6% | 4,632,759 | +17.8% | 0.01% | +20.0% |
| Q2 2021 | $164,092,000 | +42.8% | 3,932,207 | +22.0% | 0.01% | +66.7% |
| Q1 2021 | $114,908,000 | +88.7% | 3,224,178 | +48.5% | 0.00% | +50.0% |
| Q4 2020 | $60,886,000 | – | 2,170,563 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $216,810,330 | 13.15% |
| 12 West Capital Management LP | 6,463,111 | $64,631,110 | 5.85% |
| Alpine Peaks Capital, LP | 359,300 | $3,593,000 | 2.50% |
| Connacht Asset Management LP | 24,155 | $241,550 | 1.43% |
| QVIDTVM Management LLC | 163,230 | $1,632,300 | 1.27% |
| BRAIDWELL LP | 3,974,857 | $39,748,570 | 1.26% |
| Mesirow Institutional Investment Management, Inc. | 926,277 | $9,262,770 | 0.94% |
| Granite Investment Partners, LLC | 1,488,359 | $14,883,590 | 0.62% |
| CARLSON CAPITAL L P | 635,000 | $6,350,000 | 0.50% |
| Pier Capital, LLC | 290,563 | $2,905,630 | 0.47% |